Literature DB >> 2766179

Excipients in topical corticosteroid preparations in Canada.

G E Searles1, J P DesGroseilliers.   

Abstract

Topical corticosteroids are widely used for the treatment of dermatoses in Canada. The effects of the various nontherapeutic components of these formulations are less well known than those of the active ingredients and may cause adverse reactions. Information on the components is fragmentary and is scattered throughout the literature. We have attempted to consolidate this information into one source. Recent provincial legislation requiring the generic substitution of interchangeable products and the nondisclosure of all ingredients in product labelling hinder the search for an excipient that has caused an adverse reaction. Practitioner participation in the Cutaneous Adverse Reaction Registry of the Canadian Dermatology Association will identify sensitizing excipients and will support efforts by the profession to obtain more effective and safer products.

Mesh:

Substances:

Year:  1989        PMID: 2766179      PMCID: PMC1451406     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  2 in total

1.  The patch test--who should and should not use it and why.

Authors:  M B Sulzberger
Journal:  Contact Dermatitis       Date:  1975       Impact factor: 6.600

2.  Are generic formulations equivalent to trade name topical glucocorticoids?

Authors:  R B Stoughton
Journal:  Arch Dermatol       Date:  1987-10
  2 in total
  1 in total

Review 1.  Development and Clinical Application of Phosphorus-Containing Drugs.

Authors:  Hanxiao Yu; He Yang; Enxue Shi; Wenjun Tang
Journal:  Med Drug Discov       Date:  2020-08-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.